Abstract
In search of new antimicrobial agents with improved potency, we have synthesized a series of N-substituted thiazolidinedione-pyrazole based 3-(3-(1H-pyrrol-1-yl)propyl)-5-((3-(substituted phenyl)-1-phenyl-1H-pyrazol-4-yl) methylene)thiazolidine-2,4-diones (6a-j) in two successive steps. Initial step involves Knoevenagel type condensation of 3-(substituted phenyl)-1-phenyl-1H-pyrazole-4-carbaldehydes (2a-j) with thiazolidine-2,4-dione (3) to furnish intermediate compounds (4a-j). Finally, target compounds (6a-j) were achieved via one-pot reaction of compounds (4a-j), 1,3-dibromopropane and 1H-pyrrole (5). The chemical structures of all the newly synthesized compounds were established based on IR, 1H NMR, 13C NMR and mass spectra. All the synthesized compounds (4a-j, 6a-j) were evaluated for their in vitro antimicrobial activity.
Keywords: Antimicrobial, knoevenagel, MIC, SAR, thiazolidinedione-pyrazole.
Anti-Infective Agents
Title:Synthesis and Evaluation of N-Substituted Thiazolidine-2,4-dione Containing Pyrazole as a Potent Antimicrobial Agents
Volume: 12 Issue: 1
Author(s): Nisheet C. Desai, Hitesh M. Satodiya, Kiran M. Rajpara, Vivek V. Joshi, Kandarp Bhatt and Hasit V. Vaghani
Affiliation:
Keywords: Antimicrobial, knoevenagel, MIC, SAR, thiazolidinedione-pyrazole.
Abstract: In search of new antimicrobial agents with improved potency, we have synthesized a series of N-substituted thiazolidinedione-pyrazole based 3-(3-(1H-pyrrol-1-yl)propyl)-5-((3-(substituted phenyl)-1-phenyl-1H-pyrazol-4-yl) methylene)thiazolidine-2,4-diones (6a-j) in two successive steps. Initial step involves Knoevenagel type condensation of 3-(substituted phenyl)-1-phenyl-1H-pyrazole-4-carbaldehydes (2a-j) with thiazolidine-2,4-dione (3) to furnish intermediate compounds (4a-j). Finally, target compounds (6a-j) were achieved via one-pot reaction of compounds (4a-j), 1,3-dibromopropane and 1H-pyrrole (5). The chemical structures of all the newly synthesized compounds were established based on IR, 1H NMR, 13C NMR and mass spectra. All the synthesized compounds (4a-j, 6a-j) were evaluated for their in vitro antimicrobial activity.
Export Options
About this article
Cite this article as:
Desai Nisheet C., Satodiya Hitesh M., Rajpara Kiran M., Joshi Vivek V., Bhatt Kandarp and Vaghani Hasit V., Synthesis and Evaluation of N-Substituted Thiazolidine-2,4-dione Containing Pyrazole as a Potent Antimicrobial Agents , Anti-Infective Agents 2014; 12 (1) . https://dx.doi.org/10.2174/22113525113119990117
DOI https://dx.doi.org/10.2174/22113525113119990117 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Role of Adenosine Receptors in Rare Neurodegenerative Diseases with Motor Symptoms
Current Protein & Peptide Science The Effects of Creatine Supplementation and Physical Exercise on Traumatic Brain Injury
Mini-Reviews in Medicinal Chemistry Recent Updates on Glucokinase Activators for the Treatment of Type 2 Diabetes Mellitus
Mini-Reviews in Medicinal Chemistry Oxidative Stress in the Hypothalamus: the Importance of Calcium Signaling and Mitochondrial ROS in Body Weight Regulation
Current Neuropharmacology Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis
Current Molecular Medicine Adult Stem Cell Treatment for Central Nervous System Injury
Current Tissue Engineering (Discontinued) At the “Junction” of Spinal Muscular Atrophy Pathogenesis: The Role of Neuromuscular Junction Dysfunction in SMA Disease Progression
Current Molecular Medicine Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development
CNS & Neurological Disorders - Drug Targets Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins
Current Topics in Medicinal Chemistry Neurodegenerative Diseases of the Retina and Potential for Protection and Recovery
Current Neuropharmacology Role of Statins in Diabetes Complications
Current Diabetes Reviews Biomarkers and Future Targets for Development in Amyotrophic Lateral Sclerosis
Current Medicinal Chemistry Interferon-γ-Induced Neurotoxicity of Human Astrocytes
CNS & Neurological Disorders - Drug Targets Double-Faced Role of Human Mesenchymal Stem Cells and their Role/Challenges in Cancer Therapy
Current Stem Cell Research & Therapy Recent Development of Peptide Drugs and Advance on Theory and Methodology of Peptide Inhibitor Design
Medicinal Chemistry Childhood Maltreatment and Stress-Related Psychopathology: The Epigenetic Memory Hypothesis
Current Pharmaceutical Design Down-Regulation of Angiogenic Inhibitors: A Potential Pathogenic Mechanism for Diabetic Complications
Current Diabetes Reviews Meet Our Editorial Board Member
Recent Patents on CNS Drug Discovery (Discontinued)